Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Spinal cord stimulation (SCS) systems are indicated as an aid in the management of chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, nonsurgical back pain (without prior surgery and not a candidate for back surgery), and diabetic peripheral neuropathy of the lower extremities. Spinal Column Stimulation A spinal cord stimulator (SCS) is a small device, similar to a pacemaker, that uses electrical impulses to relieve chronic pain of the back, arms, and legs. The device masks pain signals before they reach the brain. Spinal cord stimulation (SCS) systems are indicated as an aid in the management of chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, nonsurgical back pain, and diabetic peripheral neuropathy of the lower extremities. Spinal Column Stimulation (SCS) Systems is designed to deliver low-intensity electrical impulses to nerve structures. The system is intended to be used with leads and associated extensions that are compatible with the system. SCS systems have a small implanted pulse generator, called a stimulator, and thin wires called leads. These are implanted into your body. The stimulator delivers tiny pulses of mild electric current through the leads to specific nerves on the spinal cord. These impulses mask pain signals traveling to the brain. There are a few types of SCS implants, but each is comprised of three main parts: A battery-powered pulse generator which creates the electrical charge. A lead wire with several electrodes which deliver an electrical charge to the spinal cord. A hand-held remote to power the device on and off and to adjust the settings.
Global Spinal Column Stimulation (SCS) Systems market is projected to reach US$ 3734 million in 2029, increasing from US$ 2100 million in 2022, with the CAGR of 8.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Spinal Column Stimulation (SCS) Systems market research.
Key manufacturers engaged in the Spinal Column Stimulation (SCS) Systems industry include Abbott, Boston Scientific Corporation, Medtronic, Nevro, Johns Hopkins Medicine, Axonics Modulation Technologies, ReShape Lifesciences Inc, Cyberonics and SceneRay, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Spinal Column Stimulation (SCS) Systems were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Spinal Column Stimulation (SCS) Systems market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Spinal Column Stimulation (SCS) Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Segment by Type
Segment by Application
Consumption by Region
The Spinal Column Stimulation (SCS) Systems report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Spinal Column Stimulation (SCS) Systems Market Overview
1.1 Product Overview and Scope of Spinal Column Stimulation (SCS) Systems
1.2 Spinal Column Stimulation (SCS) Systems Segment by Type
1.2.1 Global Spinal Column Stimulation (SCS) Systems Market Value Comparison by Type (2023-2029)
1.2.2 Rechargeable
1.2.3 Battery-Operated
1.3 Spinal Column Stimulation (SCS) Systems Segment by Application
1.3.1 Global Spinal Column Stimulation (SCS) Systems Market Value by Application: (2023-2029)
1.3.2 Regional Pain Syndromes
1.3.3 Lumbar Spine Failure Syndrome
1.3.4 Neuropathic Pain in Limbs
1.3.5 Other
1.4 Global Spinal Column Stimulation (SCS) Systems Market Size Estimates and Forecasts
1.4.1 Global Spinal Column Stimulation (SCS) Systems Revenue 2018-2029
1.4.2 Global Spinal Column Stimulation (SCS) Systems Sales 2018-2029
1.4.3 Global Spinal Column Stimulation (SCS) Systems Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Spinal Column Stimulation (SCS) Systems Market Competition by Manufacturers
2.1 Global Spinal Column Stimulation (SCS) Systems Sales Market Share by Manufacturers (2018-2023)
2.2 Global Spinal Column Stimulation (SCS) Systems Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Spinal Column Stimulation (SCS) Systems Average Price by Manufacturers (2018-2023)
2.4 Global Spinal Column Stimulation (SCS) Systems Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Spinal Column Stimulation (SCS) Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Spinal Column Stimulation (SCS) Systems, Product Type & Application
2.7 Spinal Column Stimulation (SCS) Systems Market Competitive Situation and Trends
2.7.1 Spinal Column Stimulation (SCS) Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Spinal Column Stimulation (SCS) Systems Players Market Share by Revenue
2.7.3 Global Spinal Column Stimulation (SCS) Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Spinal Column Stimulation (SCS) Systems Retrospective Market Scenario by Region
3.1 Global Spinal Column Stimulation (SCS) Systems Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Spinal Column Stimulation (SCS) Systems Global Spinal Column Stimulation (SCS) Systems Sales by Region: 2018-2029
3.2.1 Global Spinal Column Stimulation (SCS) Systems Sales by Region: 2018-2023
3.2.2 Global Spinal Column Stimulation (SCS) Systems Sales by Region: 2024-2029
3.3 Global Spinal Column Stimulation (SCS) Systems Global Spinal Column Stimulation (SCS) Systems Revenue by Region: 2018-2029
3.3.1 Global Spinal Column Stimulation (SCS) Systems Revenue by Region: 2018-2023
3.3.2 Global Spinal Column Stimulation (SCS) Systems Revenue by Region: 2024-2029
3.4 North America Spinal Column Stimulation (SCS) Systems Market Facts & Figures by Country
3.4.1 North America Spinal Column Stimulation (SCS) Systems Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Spinal Column Stimulation (SCS) Systems Sales by Country (2018-2029)
3.4.3 North America Spinal Column Stimulation (SCS) Systems Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Spinal Column Stimulation (SCS) Systems Market Facts & Figures by Country
3.5.1 Europe Spinal Column Stimulation (SCS) Systems Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Spinal Column Stimulation (SCS) Systems Sales by Country (2018-2029)
3.5.3 Europe Spinal Column Stimulation (SCS) Systems Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Spinal Column Stimulation (SCS) Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Spinal Column Stimulation (SCS) Systems Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Spinal Column Stimulation (SCS) Systems Sales by Country (2018-2029)
3.6.3 Asia Pacific Spinal Column Stimulation (SCS) Systems Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Spinal Column Stimulation (SCS) Systems Market Facts & Figures by Country
3.7.1 Latin America Spinal Column Stimulation (SCS) Systems Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Spinal Column Stimulation (SCS) Systems Sales by Country (2018-2029)
3.7.3 Latin America Spinal Column Stimulation (SCS) Systems Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Spinal Column Stimulation (SCS) Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Spinal Column Stimulation (SCS) Systems Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Spinal Column Stimulation (SCS) Systems Sales by Country (2018-2029)
3.8.3 Middle East and Africa Spinal Column Stimulation (SCS) Systems Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Spinal Column Stimulation (SCS) Systems Sales by Type (2018-2029)
4.1.1 Global Spinal Column Stimulation (SCS) Systems Sales by Type (2018-2023)
4.1.2 Global Spinal Column Stimulation (SCS) Systems Sales by Type (2024-2029)
4.1.3 Global Spinal Column Stimulation (SCS) Systems Sales Market Share by Type (2018-2029)
4.2 Global Spinal Column Stimulation (SCS) Systems Revenue by Type (2018-2029)
4.2.1 Global Spinal Column Stimulation (SCS) Systems Revenue by Type (2018-2023)
4.2.2 Global Spinal Column Stimulation (SCS) Systems Revenue by Type (2024-2029)
4.2.3 Global Spinal Column Stimulation (SCS) Systems Revenue Market Share by Type (2018-2029)
4.3 Global Spinal Column Stimulation (SCS) Systems Price by Type (2018-2029)
5 Segment by Application
5.1 Global Spinal Column Stimulation (SCS) Systems Sales by Application (2018-2029)
5.1.1 Global Spinal Column Stimulation (SCS) Systems Sales by Application (2018-2023)
5.1.2 Global Spinal Column Stimulation (SCS) Systems Sales by Application (2024-2029)
5.1.3 Global Spinal Column Stimulation (SCS) Systems Sales Market Share by Application (2018-2029)
5.2 Global Spinal Column Stimulation (SCS) Systems Revenue by Application (2018-2029)
5.2.1 Global Spinal Column Stimulation (SCS) Systems Revenue by Application (2018-2023)
5.2.2 Global Spinal Column Stimulation (SCS) Systems Revenue by Application (2024-2029)
5.2.3 Global Spinal Column Stimulation (SCS) Systems Revenue Market Share by Application (2018-2029)
5.3 Global Spinal Column Stimulation (SCS) Systems Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Spinal Column Stimulation (SCS) Systems Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boston Scientific Corporation Spinal Column Stimulation (SCS) Systems Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medtronic Spinal Column Stimulation (SCS) Systems Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Nevro
6.4.1 Nevro Corporation Information
6.4.2 Nevro Description and Business Overview
6.4.3 Nevro Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nevro Spinal Column Stimulation (SCS) Systems Product Portfolio
6.4.5 Nevro Recent Developments/Updates
6.5 Johns Hopkins Medicine
6.5.1 Johns Hopkins Medicine Corporation Information
6.5.2 Johns Hopkins Medicine Description and Business Overview
6.5.3 Johns Hopkins Medicine Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Johns Hopkins Medicine Spinal Column Stimulation (SCS) Systems Product Portfolio
6.5.5 Johns Hopkins Medicine Recent Developments/Updates
6.6 Axonics Modulation Technologies
6.6.1 Axonics Modulation Technologies Corporation Information
6.6.2 Axonics Modulation Technologies Description and Business Overview
6.6.3 Axonics Modulation Technologies Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Axonics Modulation Technologies Spinal Column Stimulation (SCS) Systems Product Portfolio
6.6.5 Axonics Modulation Technologies Recent Developments/Updates
6.7 ReShape Lifesciences Inc
6.6.1 ReShape Lifesciences Inc Corporation Information
6.6.2 ReShape Lifesciences Inc Description and Business Overview
6.6.3 ReShape Lifesciences Inc Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ReShape Lifesciences Inc Spinal Column Stimulation (SCS) Systems Product Portfolio
6.7.5 ReShape Lifesciences Inc Recent Developments/Updates
6.8 Cyberonics
6.8.1 Cyberonics Corporation Information
6.8.2 Cyberonics Description and Business Overview
6.8.3 Cyberonics Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cyberonics Spinal Column Stimulation (SCS) Systems Product Portfolio
6.8.5 Cyberonics Recent Developments/Updates
6.9 SceneRay
6.9.1 SceneRay Corporation Information
6.9.2 SceneRay Description and Business Overview
6.9.3 SceneRay Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2018-2023)
6.9.4 SceneRay Spinal Column Stimulation (SCS) Systems Product Portfolio
6.9.5 SceneRay Recent Developments/Updates
6.10 RISHNA
6.10.1 RISHNA Corporation Information
6.10.2 RISHNA Description and Business Overview
6.10.3 RISHNA Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2018-2023)
6.10.4 RISHNA Spinal Column Stimulation (SCS) Systems Product Portfolio
6.10.5 RISHNA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Spinal Column Stimulation (SCS) Systems Industry Chain Analysis
7.2 Spinal Column Stimulation (SCS) Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Spinal Column Stimulation (SCS) Systems Production Mode & Process
7.4 Spinal Column Stimulation (SCS) Systems Sales and Marketing
7.4.1 Spinal Column Stimulation (SCS) Systems Sales Channels
7.4.2 Spinal Column Stimulation (SCS) Systems Distributors
7.5 Spinal Column Stimulation (SCS) Systems Customers
8 Spinal Column Stimulation (SCS) Systems Market Dynamics
8.1 Spinal Column Stimulation (SCS) Systems Industry Trends
8.2 Spinal Column Stimulation (SCS) Systems Market Drivers
8.3 Spinal Column Stimulation (SCS) Systems Market Challenges
8.4 Spinal Column Stimulation (SCS) Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research